Medicinal cannabis trial begins for Australian veterans with PTSD
ABCAn Australian-first trial using medicinal cannabis to treat returned servicemen and women suffering from post-traumatic stress disorder has been launched today that targets defence personnel who have not had a response to conventional treatments. Key points: Researchers are seeking 300 people to take part in the national trial, which has attracted attention from the veteran community The Australian Defence Force reports about 8.3 per cent of its members have experienced PTSD in the past 12 months The ADF says the rate among males is almost double the general community The investigation, coordinated by Cannabis Access Clinics, will run over the next 12 months. "They might be on the product for up to five weeks — obviously it's an observational trial, so they'll assess the benefits that the product is offering the patient," Ms Patterson said. "I would like to see CBD-only oil reclassified — it has no psychoactive effects whatsoever," Dr Davis said. "I think the veterans having another avenue to help with signs and symptoms and treatment of PTSD can only be beneficial for us," Mr Handley said.